180 Life Sciences’ Woody Sets Out Vision For Repurposing Anti-TNF Biologics

CEO Expands On Recent Announcement Of Collaboration With Celltrion

 
• By David Wallace
Three Targets Arrows
Three new indications are being targeted by the company • Source: Alamy

More from Deals

More from Business